About Kopra Bio
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.
- Founded
- 2024
- Employees
- 2
- Headquarters
- San Francisco
Leadership
The top of Kopra Bio's org chart, with how many people report into each leader.
AB
Andrew Bartynski
CEO
Jobs at Kopra Bio
No open positions right now. Explore more companies on TheJobsMap.